Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels
Author(s) -
Nicolai Egholt Munk,
Jakob S. Knudsen,
Anton Pottegård,
Daniel R. Witte,
Reimar W. Thomsen
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2019.20949
Subject(s) - empagliflozin , medicine , glycated hemoglobin , randomized controlled trial , interquartile range , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom